Interestingly, mice lacking S100A9 showed significantly reduced tumor incidence, growth and metastasis, reduced chemokine levels, and reduced infiltration of CD11b+ Gr1+ cells within tumors and pre-metastatic organs. This evidence concerns the gene ITGAM and neoplasm.